Skip to main content

Table 1 Characteristics of the included patients

From: The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis

 

All patients (n = 110)

Demographic and disease variables

 Male (%)

60.3

 Diagnosis ALS/PMA (% ALS)

84.0

 Onset spinal/bulbar/both (%)

60.3 / 23.7 / 16.0

 Age at referral (years)

61.5 ± 12.0

 Disease duration (years)°

2.0 ± 1.7

 Mortality (n)°

67

Variables at first evaluation at the HVS

 Interval referral and first HVS assessment (weeks)

5.6 ± 5.1

 PCO2 (mmHg)

39.4 ± 5.6

 Bicarbonate (mmol/L)

26.40 ± 3.69

 Follow up until NIV (months)*

9 ± 8

  1. Values are mean (SD) unless stated otherwise. Time of death was checked in the Municipal Personal Database at January 1th, 2016 [38]. °Missing data of 20 patients, n = 90. *Only patients who received an NIV indication, n = 87. ALS Amyotrophic lateral sclerosis, PMA Progressive Muscular Atrophy, HVS Home ventilation services, NIV Non-invasive ventilation